Related Experiment Video
Updated: Jan 9, 2026
Author Spotlight: High-Throughput Screening of CAR T-Cell Constructs for Enhanced Cytotoxicity and Immunologic Memory
Published on: October 27, 2023
A rapid method of evaluating cytotoxic drug efficacy using sub-cellular fluctuation imaging
Henrik Rehnstrom1,2,3, Arthur Eley1,2, Natasha S Clayton2
1School of Physics, University of Bristol, Tyndall Avenue, Bristol, BS8 1TL, UK.
Abstract:
Determining whether potential cancer therapies effectively kill cancer cells is important for informing effective therapeutic choice for patients. Here we describe a rapid label-free method for testing drug efficacy in vitro that evaluates cellular viability from sub-cellular fluctuation imaging (SCFI). We used staurosporine and paclitaxel as known cytotoxic drugs at different concentrations, and four different human cancer-derived cell lines: PC3 (prostate), Caco-2 (colorectal), Calu-3 (lung) and A549 (lung). Both drugs caused a rapid decrease in sub-cellular fluctuations within 1 to 3 h except when the specific cell line was known to be resistant to one of the drugs. We also demonstrated that the method is able to differentiate between treated and untreated PC3 cells within 3 to 4 h after cells have been plated, thus eliminating the need for overnight incubation, and further decreasing the total time needed to evaluate drug efficacy. SCFI is therefore able to identify reliably if drugs are cytotoxic within 3 h of addition, which is considerably faster than current commonly used techniques.
Insights
This study introduces a rapid, label-free method using sub-cellular fluctuation imaging (SCFI) to test cancer drug efficacy. SCFI quickly determines if cancer therapies kill cells, improving treatment choices.
Area of Science:
- Biotechnology
- Cancer Research
- Cell Biology
Background:
- Evaluating cancer therapy effectiveness is crucial for patient treatment.
- Current methods for assessing drug efficacy can be time-consuming.
Purpose of the Study:
- To develop and validate a rapid, label-free in vitro method for testing cancer drug efficacy.
- To assess cellular viability using sub-cellular fluctuation imaging (SCFI).
Main Methods:
- Utilized staurosporine and paclitaxel as cytotoxic drugs.
- Tested efficacy across four human cancer cell lines (PC3, Caco-2, Calu-3, A549).
- Employed sub-cellular fluctuation imaging (SCFI) to evaluate cellular viability.
Main Results:
- Both drugs induced a rapid decrease in sub-cellular fluctuations within 1-3 hours.
- The method identified drug resistance in specific cell lines.
- SCFI differentiated treated from untreated cells within 3-4 hours, reducing incubation time.
Conclusions:
- SCFI offers a significantly faster alternative to current techniques for evaluating drug cytotoxicity.
- This method can reliably identify cytotoxic drugs within 3 hours of addition.
- The technique has potential to expedite therapeutic choice for cancer patients.
